Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details - Activity associated with warrants)

v3.24.1.u1
DERIVATIVE FINANCIAL INSTRUMENTS AND WARRANT LIABILITIES (Details - Activity associated with warrants)
3 Months Ended
Mar. 31, 2024
USD ($)
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 $ 5,971,067
Gain on changes in fair value 20,004,342
Exercise of warrants (17,387,486)
Balance at March 31, 2024 8,587,923
Series A Warrants [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 4,705,245
Gain on changes in fair value 12,733,180
Exercise of warrants (17,352,653)
Balance at March 31, 2024 85,772
Series B Warrants [Member]  
Derivative Instruments, Gain (Loss) [Line Items]  
Fair value on December 31, 2023 1,265,822
Gain on changes in fair value 7,271,162
Exercise of warrants (34,833)
Balance at March 31, 2024 $ 8,502,151